2-fluorofucose (SGN-2FF) / Pfizer 
Welcome,         Profile    Billing    Logout  
 0 Diseases   0 Trials   0 Trials   10 News 
  • ||||||||||  2-fluorofucose (SGN-2FF) / Pfizer
    Trial termination, PD(L)-1 Biomarker, Metastases:  A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors (clinicaltrials.gov) -  Jul 18, 2019   
    P1,  N=47, Terminated, 
    The agent shows pre-clinical efficacy for both cancer treatment and prevention. Active, not recruiting --> Terminated; Due to overall benefit/risk profile
  • ||||||||||  2-fluorofucose (SGN-2FF) / Pfizer
    Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date, PD(L)-1 Biomarker, Metastases:  A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors (clinicaltrials.gov) -  Apr 10, 2019   
    P1,  N=47, Active, not recruiting, 
    Active, not recruiting --> Terminated; Due to overall benefit/risk profile Recruiting --> Active, not recruiting | N=308 --> 47 | Trial completion date: Aug 2022 --> Jun 2019 | Trial primary completion date: Dec 2019 --> Jun 2019
  • ||||||||||  2-fluorofucose (SGN-2FF) / Pfizer
    Enrollment change, Trial completion date, Trial primary completion date, PD(L)-1 Biomarker, Metastases:  A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors (clinicaltrials.gov) -  Mar 12, 2018   
    P1,  N=308, Recruiting, 
    Recruiting --> Active, not recruiting | N=308 --> 47 | Trial completion date: Aug 2022 --> Jun 2019 | Trial primary completion date: Dec 2019 --> Jun 2019 N=158 --> 308 | Trial completion date: May 2022 --> Aug 2022 | Trial primary completion date: Jul 2019 --> Dec 2019
  • ||||||||||  2-fluorofucose (SGN-2FF) / Pfizer
    Enrollment open, Trial primary completion date, PD(L)-1 Biomarker, Metastases:  A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors (clinicaltrials.gov) -  Mar 29, 2017   
    P1,  N=158, Recruiting, 
    N=158 --> 308 | Trial completion date: May 2022 --> Aug 2022 | Trial primary completion date: Jul 2019 --> Dec 2019 Not yet recruiting --> Recruiting | Trial primary completion date: May 2018 --> Jul 2019